Because AKT is rapidly repressed in response to C75-induced blockade of FASN activity [124, 125], our findings suggest a positive feedback regulation between FASN and autocrine prolactin expression via AKT-driven activation of the PRLR/JAK/STAT5 pathways in PR+ breast cancer cells. The gene discussed is PRL; the disease is breast cancer.